• 33 Citations
  • 3 h-Index
20092016
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kevin Grewal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Management Audit Medicine & Life Sciences
Galactosidases Medicine & Life Sciences
Transjugular Intrahepatic Portasystemic Shunt Medicine & Life Sciences
End Stage Liver Disease Medicine & Life Sciences
Insurance Coverage Medicine & Life Sciences
Tacrolimus Medicine & Life Sciences
Health Insurance Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2009 2016

  • 33 Citations
  • 3 h-Index
  • 4 Article
  • 1 Letter
1 Citation (Scopus)

IgG4-related disease presenting as a lung mass and weight loss: Case report and review of the literature

Grewal, K., Cohen, P., Kwon, J. S. & Kaufman, D. A., Jan 1 2016, In : Respiratory Medicine Case Reports. 17, p. 27-29 3 p.

Research output: Contribution to journalArticle

Open Access
Weight Loss
Immunoglobulin G
Lung
Lung Diseases
Neoplasms

Auditing access to primary care for elderly adults with public insurance

Grewal, K. S., Sundararaju, V., Farah, A., Connolly, D., Rodgers, N., Horowitz, D., Amoateng-Adjepong, Y. & Manthous, C. A., May 27 2013, In : Journal of the American Geriatrics Society. 61, 5, p. 829-830 2 p.

Research output: Contribution to journalLetter

Management Audit
Insurance Coverage
Health Insurance
Insurance
Primary Health Care
21 Citations (Scopus)

MELD Score Less Than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation

Feyssa, E., Ortiz, J., Grewal, K., Azhar, A., Parsikia, A., Tufail, K., Hashemi, N., Brady, P. & Araya, V., Apr 15 2011, In : Transplantation. 91, 7, p. 786-792 7 p.

Research output: Contribution to journalArticle

Transjugular Intrahepatic Portasystemic Shunt
End Stage Liver Disease
Ascites
Liver Transplantation
Survival
4 Citations (Scopus)

Falsely elevated tacrolimus levels caused by immunoassay interference secondary to β-galactosidase antibodies in an infected liver transplant recipient

Knorr, J. P., Grewal, K. S., Balasubramanian, M., Young, N., Zaki, R., Khanmoradi, K., Araya, V. & Ortiz, J., Jan 1 2010, In : Pharmacotherapy. 30, 9, p. 339e-343e

Research output: Contribution to journalArticle

Galactosidases
Tacrolimus
Immunoassay
Antibodies
Liver

An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease

Olson, M. R., Grewal, K. S., Bingaman, A., Zaki, R., Stewart, S., Horton, J., Araya, V. & Ortiz, J., Dec 1 2009, In : Experimental and Clinical Transplantation. 7, 4, p. 203-213 11 p.

Research output: Contribution to journalArticle

Hepatitis C
Chronic Kidney Failure
Guidelines
Physicians
Chronic Renal Insufficiency